Courts reject Medicare price negotiation lawsuits from Merck, AZ
Courts in Maryland and Washington, D.C., have rejected lawsuits by two pharma giants against the Centers for Medicare…
As global drug giants grow cautious, can Chinese biotech keep cashing in on out-licensing?
Record-breaking cross-border deals helped make some formerly loss-making Chinese biotech companies profitable in the first half of the…
AstraZeneca Vietnam requests revocation of pharmaceutical business certificate to transition warehouse infrastructure
AstraZeneca Vietnam voluntarily had its pharmaceutical business certificate withdrawn as part…
Hong Kong-listed Keymed Biosciences’ gastric cancer drug meets late-stage trial goals
July 28 (Reuters) – Hong Kong-listed Keymed Biosciences said on Tuesday a late-stage trial of sonesitatug vedotin, a…
AstraZeneca (LSE:AZN) Wins Two EU Cancer Approvals And Starts Abbisko Lung Trial
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
AstraZeneca Turns to AI Agent to Cut Drug Discovery Time
Artificial Intelligence & Machine Learning , Healthcare , Industry Specific Owkin AI Will Analyze Trials, Forecasts, Other Rival…
Compugen Highlights AI-Driven IO Pipeline, Key Trial Timelines and Big Pharma Partnerships at Needham Conference
Compugen logo Compugen leverages its AI-driven discovery engine, Unigen, to identify novel immuno-oncology targets and advance select assets…
Global drug makers face pricing pressure as China targets affordable healthcare
Global pharmaceutical companies posted mixed earnings in China last year, with some firms warning that 2026 will be…
Capital injection: China backs AI drug makers in self-reliance drive
Hangzhou-based METiS TechBio, founded in 2020, raised 400 million yuan (US$57.9 million) in series D financing in August…
GLP-1s, taste and what’s happening to our diets
Trump announces lower prices coming for GLP-1 drugs Zepbound, Wegovy President Donald Trump announces discounted pricing for Zepbound…
Exclusive | AI tops the mind of this fifth-generation Illinois farmer in China-owned Syngenta’s mega IPO
Jeff Rowe grinned with satisfaction when the dashboard of his John Deere combine harvester showed the yield of…
Updated: CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks – Endpoints News
Updated: CMS unveils negotiated prices for Ozempic, Wegovy and other drugs from second round of IRA talks Endpoints NewsMedicare…